Skye Bioscience, Inc. (SKYE) has 5 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 4 sales totalling $410K. Most recent filing: Sept. 18, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 18, 2026 filed Sept. 16, 2026 | Schwab Andrew J. Director | −$64,734 | 33,892 | −86% | No | |
|
|
||||||
| Sept. 18, 2026 filed Sept. 16, 2026 | 5AM Partners VII, LLC 10% Owner | −$64,734 | 33,892 | −86% | No | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 18, 2026 | Schwab Andrew J. Director | −$140,313 | 375,840 | −5% | No | |
|
|
||||||
| Aug. 20, 2026 filed Aug. 18, 2026 | 5AM Partners VII, LLC 10% Owner | −$140,313 | 375,840 | −5% | No | |
|
|
||||||
| Aug. 7, 2026 | DHILLON PUNIT Chief Executive Officer | $0 | 1,090,000 | +330% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free